Table 1 Three hundred seventy Subjects with clinical diagnosis of mild to moderate AD and known ApoE ɛ 4 genotype (adapted from the Degenhardt publication in Psychosomatics in 2016)
From: Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
Amyloid FBP PET positive* | Amyloid FBP PET negative* | Totals | Accuracy of clinical diagnosis | |
|---|---|---|---|---|
ApoE ɛ 4(−) | 107 | 65 | 172 | 62% |
ApoE ɛ 4(+/−) | 133 | 18 | 151 | 88% |
ApoE ɛ 4(+) | 46 | 1 | 47 | 98% |